Summary
Liquid-liquid phase separation (LLPS) is the process by which proteins and nucleic acids demix from the cytoplasm to form concentrated, membrane-less condensates. Driven by multivalent weak interactions, LLPS underlies the formation of stress granules, nucleoli, and other biomolecular condensates.
Key Points
- 1Demixing creates membrane-less compartments via thermodynamic phase separation
- 2Driven by multivalent weak interactions between IDRs, modular domains, and RNA
- 3Underlies nucleoli, stress granules, P-bodies, and other condensates
- 4Dysregulation linked to neurodegeneration and cancer
Liquid-liquid phase separation has emerged as a fundamental organizing principle in cell biology, explaining how cells create distinct compartments without membranes.
Physical Principles
Phase Separation Basics
LLPS is governed by thermodynamics:
- Demixing: Homogeneous solution separates into two phases
- Dense phase: Concentrated in macromolecules (condensate)
- Dilute phase: Depleted of macromolecules (surrounding cytoplasm)
- Phase boundary: Sharp interface, no membrane required
Thermodynamic Framework
Phase separation occurs when:
ΔG_mix = ΔH_mix - TΔS_mix > 0
For demixing:
- Favorable interactions within each phase outweigh mixing entropy
- Temperature dependence: UCST (upper) or LCST (lower critical solution temperature)
- Concentration threshold: Critical concentration for phase separation
Flory-Huggins Theory
Polymer physics framework applied to biomolecules:
- χ parameter: Interaction strength between components
- Polymer length: Longer polymers phase separate more readily
- Binodal curve: Defines phase boundary
Molecular Drivers
Multivalent Interactions
LLPS requires multiple weak, transient interactions:
#### Protein-Protein
- Intrinsically disordered regions (IDRs): Flexible scaffolds
- Modular domains: SH3-PRM, SH2-pTyr pairs
- Electrostatic interactions: Oppositely charged patches
#### Protein-RNA
- RNA-binding domains: RRM, KH domains
- Low-complexity sequences: RGG motifs, RS domains
- RNA structure: Multivalent scaffold
Low-Complexity Domains (LCDs)
Regions enriched in specific amino acids:
- Glycine-rich: Flexibility
- Serine/Glutamine-rich: Hydrogen bonding
- Aromatic residues: Tyr, Phe for π-π stacking
- Arginine: Cation-π interactions with aromatics
Sticker-Spacer Model
Conceptual framework for LLPS-driving sequences:
- Stickers: Residues that mediate attractive interactions
- Spacers: Provide flexibility between stickers
- Valency: Number of stickers determines phase behavior
Biomolecular Condensates
Nucleolus
Site of ribosome biogenesis:
Stress Granules
Form under cellular stress:
P-Bodies
mRNA decay and storage:
Cajal Bodies
Nuclear bodies for snRNP assembly:
Paraspeckles
Nuclear bodies formed around lncRNA NEAT1:
Material Properties
Liquid-Like Behavior
Hallmarks of liquid condensates:
- Spherical shape: Minimizes surface tension
- Fusion: Droplets coalesce upon contact
- Internal mixing: Fluorescence recovery after photobleaching (FRAP)
- Dripping/Wetting: Deformation under flow
Viscoelasticity
Condensates have complex rheology:
- Viscosity: Resistance to flow
- Elasticity: Tendency to return to shape
- Maxwell model: Viscoelastic behavior
Maturation and Aging
Condensates can change over time:
- Liquid → gel → solid: Progressive hardening
- Fibril formation: Within condensates
- Pathological aggregation: Disease-related transitions
Regulation of LLPS
Post-Translational Modifications
PTMs tune phase behavior:
- Phosphorylation: Often dissolves condensates
- Methylation: Can promote or inhibit LLPS
- Ubiquitination: Recruitment or exclusion signals
RNA
Nucleic acids modulate phase separation:
- Scaffold role: RNA as multivalent platform
- Buffering: RNA can dissolve protein condensates
- Specificity: Sequence-dependent recruitment
ATP
Active processes influence condensates:
- Chaperones: Dissolve aberrant assemblies
- RNA helicases: Remodel RNA-protein interactions
- Active dissolution: Energy-dependent fluidization
Disease Connections
Neurodegeneration
LLPS linked to multiple diseases:
#### ALS/FTD
#### Huntington's Disease
Cancer
Aberrant condensates in malignancy:
- Oncogenic fusions: Create novel condensates
- Transcriptional condensates: Super-enhancer regulation
- Therapeutic targeting: Dissolving pathological condensates